Search Results - "Yu, Marina H"

Zero-order drug delivery: State of the art and future prospects by Laracuente, Mei-Li, Yu, Marina H., McHugh, Kevin J.

“…Pharmaceutical drugs are an important part of the global healthcare system, with some estimates suggesting over 50% of the world's population takes at least…”
Get full text

Intra‐lymph node crosslinking of antigen‐bearing polymers enhances humoral immunity and dendritic cell activation by Euliano, Erin M., Agrawal, Anushka, Yu, Marina H., Graf, Tyler P., Henrich, Emily M., Kunkel, Alyssa A., Hsu, Chia‐Chien, Baryakova, Tsvetelina, McHugh, Kevin J.

“…Lymph node (LN)‐resident dendritic cells (DCs) are a promising target for vaccination given their professional antigen‐presenting capabilities and proximity to…”
Get full text

A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine Adjuvant by Euliano, Erin M, Pogostin, Brett H, Agrawal, Anushka, Yu, Marina H, Baryakova, Tsvetelina H, Graf, Tyler P, Kunkel, Alyssa A, Cahue, Kiana A, Hartgerink, Jeffrey D, McHugh, Kevin J

“…Toll-like receptors (TLRs) recognize pathogen- and damage-associated molecular patterns and, in turn, trigger the release of cytokines and other…”
Get full text

Probing the Effects of Chirality on Self-Assembling Peptides: Hydrogel Formation, Degradation, Antigen Release, and Adjuvancy by Agrawal, Anushka, Euliano, Erin M., Pogostin, Brett H., Yu, Marina H., Swain, Joseph W. R., Hartgerink, Jeffrey D., McHugh, Kevin J.

“…Introduction Multidomain peptides (MDPs) are amino acid sequences that self-assemble to form supramolecular hydrogels under physiological conditions that have…”
Get full text

Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity by Pogostin, Brett H, Yu, Marina H, Azares, Alon R, Euliano, Erin M, Lai, Cheuk Sun Edwin, Saenz, Gabriel, Wu, Samuel X, Farsheed, Adam C, Melhorn, Sarah M, Graf, Tyler P, Woodside, Darren G, Hartgerink, Jeffrey D, McHugh, Kevin J

“…Adjuvants play a critical role in enhancing vaccine efficacy; however, there is a need to develop new immunomodulatory compounds to address emerging pathogens…”
Get more information